Why Is VIRIDIAN THERAPEUTIC (VRDN) Stock Up Today?
By the Top Tier Newswire AI Desk · reviewed against 7 wire stories
VIRIDIAN THERAPEUTIC (VRDN) is up +15.53% in the latest session. Our newswire has captured 7 stories on VRDN across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 57/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for VRDN publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
VRDN · today's session (5-min) · +15.53% vs prior close · updated 4:01 PM ETAI sentiment, last 36h · averaged over 7 stories · 57/100 bullish
The headlines behind the move
Story flow · 7 stories on the wire, last 36h · hover or tap a dot for the headline
4h agoThe Motley FoolBULLISH 67Earnings
Viridian (VRDN) Q3 2026 Earnings Call Transcript
First full quarter of Lumvoa sales beat expectations as patient starts accelerated.
4h agoSeeking AlphaBULLISH 64Product/PR
Viridian signals Elegrobart BLA in Q1 2027 as Lumvoa launch targets broad coverage in 6 to 9 months
4h agoSeeking AlphaNEUTRAL 50Earnings
Viridian Therapeutics, Inc. (VRDN) Q3 2026 Earnings Call Transcript
Viridian Therapeutics, Inc. (VRDN) Q3 2026 Earnings Call November 4, 2026 8:00 AM ESTCompany ParticipantsGreg RossinoStephen Mahoney - CEO, President &...
10h agoSeeking AlphaBULLISH 63Earnings
Viridian Therapeutics GAAP EPS of -$0.81 beats by $0.21, revenue of $24.7M beats by $19.98M
Viridian Therapeutics Q3 results: EPS beat estimates and revenue topped forecasts despite a sharp Y/Y decline.
11h agoSEC 8-KNEUTRAL 50General
Viridian Therapeutics, Inc.\DE (VRDN) files 8-K
Filed: 2026-11-04 AccNo: 0001193125-26-446200 Size: 233 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
11h agoStockTitanBULLISH 56Earnings
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
1d agoSeeking AlphaNEUTRAL 50Earnings
Viridian Therapeutics Q3 2026 Earnings Preview
Frequently asked questions
Why is VRDN stock up today?
VIRIDIAN THERAPEUTIC (VRDN) is up +15.53% in the latest session. Our newswire has captured 7 stories on VRDN across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 57/100). The most recent driver: "Viridian (VRDN) Q3 2026 Earnings Call Transcript" (The Motley Fool).
Is VRDN a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of VRDN coverage reads 57/100 over 7 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →